Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials

Hannu Uusitalo, Evgeniy Egorov, Kai Kaarniranta, Yuri Astakhov, Auli Ropo

Research output: Contribution to journalArticleScientificpeer-review

24 Citations (Scopus)
Original languageEnglish
Pages (from-to)445-454
JournalClinical ophthalmology
Publication statusPublished - 2016
Publication typeA1 Journal article-refereed


  • IOP
  • Taflotan (R)
  • Xalatan (R)
  • ocular surface disease
  • ocular symptoms and signs
  • patient-related outcome
  • preserved latanoprost

Publication forum classification

  • Publication forum level 1

Cite this